Dr. Erin Murphy Talks About Treatments For Young Ependymoma Patients
Dr. Erin Murphy talks about a study presented by Dr. Thomas E. Merchant regarding young patients with ependymoma and how they can be treated effectively with a regiment of adjuvant radiation.
Erin Murphy, MD, Radiation Oncologist at Cleveland Clinic, talks about a study presented by Thomas E. Merchant, DO, PhD, Chair, Radiation Oncology Department at St. Jude Children’s Research regarding young patients with ependymoma and how they can be treated effectively with a regiment of adjuvant radiation.
Murphy says that some patients who undergo a subtotal resection for ependymoma can go on to receive chemotherapy and possibly be eligible for a gross total resection.
First-in-Class Drug AMG 193 Exploits Tumor Weakness for Targeted Therapy
September 17th 2024In a first-in-human trial, AMG 193, a drug targeting a specific mutation in tumors, showed promising results in reducing tumor size and spread in various cancers, with an acceptable safety profile.
Read More
Adaptive NSCLC Trial Misses Target Efficacy, Reaches Clinical Benefit in Some Patients
September 16th 2024The PIONeeR trial, evaluating combinations of immunotherapy drugs for advanced NSCLC, identified durvalumab plus ceralasertib as a promising treatment option, demonstrating long-term clinical benefit in some patients.
Read More
Dual HER2 Blockade Plus Ribociclib Offers Chemo-Free Option in HR+/HER2+ Breast Cancer
September 16th 2024Combining endocrine therapy with the dual HER2 blockade of trastuzumab and pertuzumab and the CDK4/6 inhibitor ribociclib showed potential as a novel approach for patients with HR+/HER2+ breast cancer.
Read More
